X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7780) 7780
Book Review (1895) 1895
Publication (259) 259
Conference Proceeding (38) 38
Magazine Article (22) 22
Book Chapter (12) 12
Book / eBook (7) 7
Dissertation (2) 2
Government Document (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
erythropoietin - therapeutic use (7751) 7751
humans (7264) 7264
index medicus (7005) 7005
male (3507) 3507
female (3377) 3377
anemia - drug therapy (2879) 2879
recombinant proteins (2847) 2847
middle aged (2499) 2499
erythropoietin (2440) 2440
anemia - etiology (2365) 2365
anemia (2150) 2150
adult (1980) 1980
aged (1881) 1881
recombinant proteins - therapeutic use (1747) 1747
recombinant-human-erythropoietin (1480) 1480
urology & nephrology (1441) 1441
kidney failure, chronic - complications (1407) 1407
renal dialysis (1210) 1210
animals (1178) 1178
kidney failure, chronic - therapy (1148) 1148
hematinics - therapeutic use (1114) 1114
erythropoietin - administration & dosage (1051) 1051
treatment outcome (1000) 1000
erythropoietin - adverse effects (944) 944
anemia - therapy (908) 908
epoetin alfa (866) 866
anemia - blood (833) 833
hematocrit (812) 812
hematology (773) 773
hemoglobins - analysis (751) 751
oncology (692) 692
erythropoietin - pharmacology (690) 690
abridged index medicus (681) 681
erythropoietin - analogs & derivatives (670) 670
hemodialysis (634) 634
blood transfusion (627) 627
darbepoetin alfa (600) 600
therapy (598) 598
quality of life (579) 579
hemoglobins - metabolism (573) 573
aged, 80 and over (546) 546
transplantation (545) 545
kidney failure, chronic - blood (542) 542
medicine, general & internal (523) 523
hemodialysis-patients (505) 505
renal dialysis - adverse effects (504) 504
rats (495) 495
prospective studies (493) 493
time factors (488) 488
quality-of-life (462) 462
adolescent (451) 451
double-blind (451) 451
hemoglobin (445) 445
neoplasms - complications (431) 431
dose-response relationship, drug (397) 397
cancer (391) 391
infant, newborn (385) 385
pharmacology & pharmacy (380) 380
retrospective studies (374) 374
anaemia (372) 372
disease (372) 372
epoetin-alpha (370) 370
anemia - chemically induced (369) 369
care and treatment (369) 369
neoplasms - drug therapy (355) 355
iron - therapeutic use (352) 352
risk factors (350) 350
surgery (338) 338
ferritins - blood (332) 332
anemia - complications (329) 329
antineoplastic agents - adverse effects (324) 324
erythropoiesis - drug effects (322) 322
mortality (321) 321
drug administration schedule (320) 320
chronic disease (319) 319
chronic kidney-disease (319) 319
recombinant human erythropoietin (318) 318
mice (315) 315
kidney failure, chronic - drug therapy (313) 313
dialysis (312) 312
pediatrics (312) 312
child (306) 306
nursing (305) 305
health aspects (303) 303
erythropoietin - blood (294) 294
clinical trials as topic (293) 293
chemotherapy (288) 288
placebo-controlled trial (282) 282
drug therapy, combination (278) 278
granulocyte colony-stimulating factor - therapeutic use (276) 276
chronic-renal-failure (274) 274
anemia - prevention & control (267) 267
iron (264) 264
erythropoietin - economics (263) 263
disease models, animal (262) 262
injections, subcutaneous (260) 260
double-blind method (257) 257
transfusion (256) 256
stage renal-disease (255) 255
randomized controlled trials as topic (254) 254
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6763) 6763
French (203) 203
Japanese (167) 167
German (133) 133
Spanish (133) 133
Polish (92) 92
Italian (73) 73
Russian (60) 60
Chinese (52) 52
Czech (31) 31
Croatian (19) 19
Hungarian (14) 14
Danish (12) 12
Dutch (12) 12
Serbian (11) 11
Portuguese (10) 10
Bulgarian (7) 7
Finnish (5) 5
Slovak (4) 4
Hebrew (3) 3
Swedish (3) 3
Turkish (3) 3
Bosnian (2) 2
Ukrainian (2) 2
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2014, Volume 124, Issue 19, pp. 2930 - 2936
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2013, Volume 32, Issue 6, pp. 633 - 640
Background The cardioprotective efficacy of erythropoietin (EPO) has been widely documented in rodent models of acute coronary syndrome. We sought to evaluate... 
Surgery | heart transplantation | heart preservation | Celsior solution | glyceryl trinitrate | zoniporide | ischemia–reperfusion injury | erythropoietin | ischemia-reperfusion injury | CARDIAC & CARDIOVASCULAR SYSTEMS | REPERFUSION INJURY | CARDIAC ALLOGRAFT PRESERVATION | PROTECTS | CARIPORIDE | TRANSPLANTATION | IN-VITRO | PATHWAY | RESPIRATORY SYSTEM | ISCHEMIA/REPERFUSION | SIGNAL TRANSDUCER | Erythropoietin - pharmacology | Electrolytes - therapeutic use | Glutamates - therapeutic use | Histidine - pharmacology | Pyrazoles - therapeutic use | Rats, Wistar | Recovery of Function - drug effects | Erythropoietin - therapeutic use | Guanidines - pharmacology | Male | Cold Ischemia | Histidine - therapeutic use | Nitroglycerin - pharmacology | Mannitol - pharmacology | Dose-Response Relationship, Drug | Disaccharides - pharmacology | Heart Rate - drug effects | Glutathione - pharmacology | Myocardial Reperfusion Injury - pathology | Cardioplegic Solutions - therapeutic use | Heart Rate - physiology | Recovery of Function - physiology | Models, Animal | Disaccharides - therapeutic use | Drug Therapy, Combination | Pyrazoles - pharmacology | Glutathione - therapeutic use | Mannitol - therapeutic use | Nitroglycerin - therapeutic use | Rats | Cardioplegic Solutions - pharmacology | Treatment Outcome | Myocardial Reperfusion Injury - physiopathology | Animals | Glutamates - pharmacology | Electrolytes - pharmacology | Hypothermia - physiopathology | Guanidines - therapeutic use | Myocardial Reperfusion Injury - prevention & control | Erythropoietin | Ischemia | Coronary heart disease | Index Medicus
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2013, Volume 145, Issue 5, pp. 1035 - 1044.e5
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 05/2010, Volume 5, Issue 5, pp. 905 - 911
Background and objectives: Vitamin D deficiency is highly prevalent in chronic kidney disease. The aim of this study was to evaluate the effects of oral... 
BRAIN NATRIURETIC PEPTIDE | 1,25-DIHYDROXYVITAMIN-D3 | 1-ALPHA-HYDROXYLASE | RENAL-FAILURE | UROLOGY & NEPHROLOGY | 25-HYDROXYVITAMIN D3 | PREVALENCE | CHRONIC KIDNEY-DISEASE | VITAMIN-D DEFICIENCY | 1,25-DIHYDROXYCHOLECALCIFEROL | BLOOD-PRESSURE | Prospective Studies | Vitamin D Deficiency - complications | Erythropoietin - therapeutic use | Humans | Middle Aged | Vitamin D Deficiency - drug therapy | Ergocalciferols - therapeutic use | Male | Polyamines - therapeutic use | Parathyroid Hormone - blood | Bone Remodeling - drug effects | Calcium - blood | Erythropoietin - analogs & derivatives | C-Reactive Protein - metabolism | Cholecalciferol - administration & dosage | Time Factors | Vitamin D Deficiency - blood | Female | Kidney Diseases - blood | Kidney Diseases - complications | Sevelamer | Chelating Agents - therapeutic use | Natriuretic Peptide, Brain - blood | Hematinics - therapeutic use | Hypertrophy, Left Ventricular - blood | Administration, Oral | Hypertrophy, Left Ventricular - etiology | Hypertrophy, Left Ventricular - prevention & control | Inflammation Mediators - blood | Bone Density Conservation Agents - therapeutic use | Kidney Diseases - drug therapy | Treatment Outcome | Biomarkers - blood | Calcitriol - blood | Vitamin D - blood | Phosphorus - blood | Kidney Diseases - therapy | Vitamin D - analogs & derivatives | Aged | Darbepoetin alfa | Chronic Disease | Dietary Supplements | Vitamins - administration & dosage | Renal Dialysis | Serum Albumin - metabolism | Index Medicus | Original
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2018, Volume 175, Issue 5, pp. 743 - 762
BACKGROUND AND PURPOSE Bruton's tyrosine kinase (Btk) is a non-receptor tyrosine kinase involved in the activation of signalling pathways responsible for cell... 
POTENT INHIBITOR | CELLS | CONCISE GUIDE | GASTRIC-CARCINOMA | IN-VIVO | PROSTATE-CANCER | GENE-EXPRESSION | BTK | CHRONIC LYMPHOCYTIC-LEUKEMIA | PHARMACOLOGY & PHARMACY | BRUTONS-TYROSINE-KINASE | Erythropoietin - pharmacology | Nitriles - pharmacology | Erythropoietin - therapeutic use | Cell Count | Colonic Neoplasms - drug therapy | Humans | Protein-Serine-Threonine Kinases | Erythropoietin - adverse effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Agammaglobulinaemia Tyrosine Kinase - metabolism | Colorectal Neoplasms - drug therapy | Amides - adverse effects | Proto-Oncogene Proteins | Proto-Oncogene Proteins c-akt - metabolism | Amides - pharmacology | Cell Survival - drug effects | Amides - therapeutic use | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Line, Tumor | Mice | Nitriles - adverse effects | Receptors, Erythropoietin - metabolism | Cell Cycle Proteins | Nitriles - therapeutic use | Tyrosine | Prevention | Erythropoietin | RNA | Analysis | Colorectal cancer | Health aspects | Cancer | Adenocarcinoma | Animal models | Growth rate | Polo-like kinase 1 | Mitosis | Colorectal carcinoma | AKT protein | mRNA | Kinases | Signal transduction | Receptors | Colon cancer | Pathways | Polo-like kinase | Protein-tyrosine kinase receptors | Colon | Hepatotoxicity | Protein-tyrosine kinase | Hematology | Anemia | Bruton's tyrosine kinase | Signaling | Cell number | Viability | Tumors | Index Medicus | Research Papers | Research Paper
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2013, Volume 368, Issue 13, pp. 1210 - 1219
In this trial, patients with systolic heart failure and anemia were assigned to receive either darbepoetin alfa or placebo. At 28 months, there was no... 
MORTALITY | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Index Medicus | Abridged Index Medicus | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article
2004, ISBN 9783527304950, 240
The use of Epo in medical practice is increasing constantly. It has revolutionized how we think of blood transfusion in medicine and surgery. Moreover, it has... 
Erythropoietin | Physiological effect | Therapeutic use
eBook
Gastroenterology, ISSN 0016-5085, 2007, Volume 132, Issue 5, pp. 1746 - 1756
Journal Article